All In MedTech

Device Trial Radar · NCT03685578

CERENOVUS Neurothrombectomy Devices Registry

Embotrap eXtraction & Clot EvaLuation & Lesion Evaluation for NeuroThrombectomy

Last checked: Nov 20, 2026Latest source record: Jun 3, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

2,000

Actual

Start

Sep 28, 2018

Primary completion

Feb 20, 2025

Study completion Feb 20, 2025

Sponsor

Lead sponsor
Cerenovus, Part of DePuy Synthes Products, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Sep 26, 2018

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A post-market registry evaluating the EmboTrap® Revascularization Device, CERENOVUS Large Bore Catheter/ EMBOVAC™ Aspiration Catheter, and CEREGLIDE 71 Intermediate Catheter in acute ischemic stroke patients with confirmed intracranial vessel occlusion.

Conditions

  • Cerebral Stroke

Interventions

  • EmboTrap® Revascularization DeviceDevice

    EmboTrap® Revascularization Device

  • CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration CatheterDevice

    CERENOVUS Large Bore Catheter/ EMBOVAC Aspiration Catheter

  • CEREGLIDE 71 Intermediate CatheterDevice

    CEREGLIDE 71 Intermediate Catheter

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Successful RevascularizationTime frame: 1 day

Locations

40 sites in 7 countries. Site status is shown where the registry gives one.

  • The University of Alabama at Birmingham

    Birmingham, Alabama

  • Banner Desert Medical Center

    Mesa, Arizona

  • Barrow Neurological Institute at St. Joseph's Hospital

    Phoenix, Arizona

37 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.